Nevro Corp.
(NYSE : NVRO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 9.71%25.656.3%$1438.74m
TMOThermo Fisher Scientific, Inc. 1.78%389.371.0%$565.47m
MDTMedtronic Plc 2.77%93.330.6%$537.73m
DXCMDexCom, Inc. -0.30%438.338.2%$524.14m
ABTAbbott Laboratories 2.46%95.330.8%$507.08m
BDXBecton, Dickinson & Co. 1.58%261.431.0%$503.27m
DHRDanaher Corp. 1.06%185.620.7%$451.34m
BSXBoston Scientific Corp. 0.63%34.901.0%$432.17m
QDELQuidel Corp. 2.10%251.837.7%$420.79m
ISRGIntuitive Surgical, Inc. 1.99%587.332.4%$340.60m
SYKStryker Corp. 1.18%179.981.3%$312.17m
BAXBaxter International, Inc. -0.23%85.041.8%$275.01m
ALGNAlign Technology, Inc. 1.50%277.386.4%$227.64m
ZBHZimmer Biomet Holdings, Inc. 2.29%122.171.7%$210.00m
BIOBio-Rad Laboratories, Inc. 1.26%483.672.9%$201.59m

Company Profile

Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.